Magnetic Resonance Spectroscopy - Revisiting the Biochemical and Molecular Milieu of Brain Tumors

Overview

Journal BBA Clin

Publisher Elsevier

Specialty Biochemistry

Date 2016 May 10

PMID 27158592

Citations 51

Authors

Ashish Verma

Ishan Kumar

Nimisha Verma

Priyanka Aggarwal

Ritu Ojha

Affiliations

Soon will be listed here.

Abstract

Background: Magnetic resonance spectroscopy (MRS) is an established tool for in-vivo evaluation of the biochemical basis of human diseases. On one hand, such lucid depiction of 'live biochemistry' helps one to decipher the true nature of the pathology while on the other hand one can track the response to therapy at sub-cellular level. Brain tumors have been an area of continuous interrogation and instigation for mankind. Evaluation of these lesions by MRS plays a crucial role in the two aspects of disease management described above.

Scope Of Review: Presented is an overview of the window provided by MRS into the biochemical aspects of brain tumors. We systematically visit each metabolite deciphered by MRS and discuss the role of deconvoluting the biochemical aspects of pathologies (here in context of brain tumors) in the disease management cycle. We further try to unify a radiologist's perspective of disease with that of a biochemist to prove the point that preclinical work is the mother of the treatment we provide at bedside as clinicians. Furthermore, an integrated approach by various scientific experts help resolve a query encountered in everyday practice.

Major Conclusions: MR spectroscopy is an integral tool for evaluation and systematic follow-up of brain tumors. A deeper understanding of this technology by a biochemist would help in a swift and more logical development of the technique while a close collaboration with radiologist would enable definitive application of the same.

General Significance: The review aims at inciting closer ties between the two specialists enabling a deeper understanding of this valuable technology.

Citing Articles

Malignant Meningiomas: From Diagnostics to Treatment.

Rowbottom H, Smigoc T, Ravnik J Diagnostics (Basel). 2025; 15(5).

PMID: 40075786 PMC: 11898517. DOI: 10.3390/diagnostics15050538.

A Comprehensive Review on the Role of MRI in the Assessment of Supratentorial Neoplasms: Comparative Insights Into Adult and Pediatric Cases.

Bhangale P, Kashikar S, Kasat P, Shrivastava P, Kumari A Cureus. 2024; 16(8):e67553.

PMID: 39310617 PMC: 11416707. DOI: 10.7759/cureus.67553.

Role of Magnetic Resonance Spectroscopy in Evaluating Choline Levels in Gallbladder Carcinoma: A Comprehensive Review.

Kumari A, Mishra G, Parihar P, Dudhe S Cureus. 2024; 16(8):e66205.

PMID: 39233932 PMC: 11374109. DOI: 10.7759/cureus.66205.

Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.

Chinnappan R, Makhzoum T, Arai M, Hajja A, Abul Rub F, Alodhaibi I Diagnostics (Basel). 2024; 14(14).

PMID: 39061656 PMC: 11276200. DOI: 10.3390/diagnostics14141519.

Sellar masses: diagnosis and treatment.

Al-Bader D, Hasan A, Behbehani R Front Ophthalmol (Lausanne). 2024; 2:970580.

PMID: 38983521 PMC: 11182331. DOI: 10.3389/fopht.2022.970580.

References

Ricci R, Bacci A, Tugnoli V, Battaglia S, Maffei M, Agati R . Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol. 2007; 28(7):1287-91. PMC: 7977674. DOI: 10.3174/ajnr.A0564. View

Lehnhardt F, Rohn G, Ernestus R, Grune M, Hoehn M . 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed. 2001; 14(5):307-17. DOI: 10.1002/nbm.708. View

Chawla S, Zhang Y, Wang S, Chaudhary S, Chou C, ORourke D . Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr. 2010; 34(6):836-41. DOI: 10.1097/RCT.0b013e3181ec554e. View

Chernov M, Ono Y, Kubo O, Hori T . Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin. Brain Tumor Pathol. 2007; 23(1):35-40. DOI: 10.1007/s10014-006-0198-5. View

Candiota A, Majos C, Julia-Sape M, Cabanas M, Acebes J, Moreno-Torres A . Non-invasive grading of astrocytic tumours from the relative contents of myo-inositol and glycine measured by in vivo MRS. JBR-BTR. 2012; 94(6):319-29. DOI: 10.5334/jbr-btr.698. View

Horska A, Barker P . Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am. 2010; 20(3):293-310. PMC: 2927327. DOI: 10.1016/j.nic.2010.04.003. View

Oberhaensli R, Hilton-Jones D, Bore P, Hands L, Rampling R, Radda G . Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet. 1986; 2(8497):8-11. DOI: 10.1016/s0140-6736(86)92558-4. View

Starr M . Uptake of taurine by retina in different species. Brain Res. 1978; 151(3):604-8. DOI: 10.1016/0006-8993(78)91094-6. View

Chuang M, Lin W, Tsai H, Liu G, Hu S, Chiang I . 3-T proton magnetic resonance spectroscopy of central neurocytoma: 3 case reports and review of the literature. J Comput Assist Tomogr. 2005; 29(5):683-8. DOI: 10.1097/01.rct.0000171240.95430.29. View

10.

Kinoshita Y, Yokota A . Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10(1):2-12. DOI: 10.1002/(sici)1099-1492(199701)10:1<2::aid-nbm442>3.0.co;2-n. View

11.

Yeh I, Xu M, Ng W, Ye J, Yang D, Tchoyoson Lim C . Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination. Magn Reson Imaging. 2007; 26(1):59-64. DOI: 10.1016/j.mri.2007.04.005. View

12.

Garcia-Gomez J, Luts J, Julia-Sape M, Krooshof P, Tortajada S, Robledo J . Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy. MAGMA. 2008; 22(1):5-18. PMC: 2797843. DOI: 10.1007/s10334-008-0146-y. View

13.

Demir M, Iplikcioglu A, Dincer A, Arslan M, Sav A . Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol. 2006; 60(1):48-55. DOI: 10.1016/j.ejrad.2006.06.002. View

14.

Lu D, Pavlakis S, Frank Y, Bakshi S, Pahwa S, Gould R . Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology. 1996; 199(2):423-8. DOI: 10.1148/radiology.199.2.8668788. View

15.

Tugnoli V, Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V . Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra. Int J Mol Med. 2006; 18(5):859-69. View

16.

Negendank W, Li C, Stoyanova R, Krigel R, Schilder R, Smith M . Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 1995; 55(15):3286-94. View

17.

Veale M, Roberts N, King G, King N . The generation of 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C. Biochem Biophys Res Commun. 1997; 239(3):868-74. DOI: 10.1006/bbrc.1997.7566. View

18.

Sato K, Yoshida S, Fujiwara K, Tada K, Tohyama M . Glycine cleavage system in astrocytes. Brain Res. 1991; 567(1):64-70. DOI: 10.1016/0006-8993(91)91436-5. View

19.

Roda J, Pascual J, Carceller F, Gonzalez-Llanos F, Perez-Higueras A, Solivera J . Nonhistological diagnosis of human cerebral tumors by 1H magnetic resonance spectroscopy and amino acid analysis. Clin Cancer Res. 2000; 6(10):3983-93. View

20.

Jayasundar R, Shah T, Vaishya S, Singh V, Sarkar C . In vivo and in vitro MR spectroscopic profile of central neurocytomas. J Magn Reson Imaging. 2003; 17(2):256-60. DOI: 10.1002/jmri.10252. View